These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8059166)

  • 1. [Hyperammonemic encephalopathy caused by sodium valproate].
    Kerleau JM; Bohu PA; Héron F; Manchon ND; Bourreille J
    Rev Med Interne; 1994 May; 15(5):363-4. PubMed ID: 8059166
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic acid-associated encephalopathy with coma.
    Settle EC
    Am J Psychiatry; 1995 Aug; 152(8):1236-7. PubMed ID: 7625483
    [No Abstract]   [Full Text] [Related]  

  • 3. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia.
    Sofi A; Herial NA; Ali II
    Am J Ther; 2013; 20(6):e703-5. PubMed ID: 20224318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-induced hyperammonemic encephalopathy.
    Chou HF; Yang RC; Chen CY; Jong YJ
    Pediatr Neonatol; 2008 Oct; 49(5):201-4. PubMed ID: 19133574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stupor encephalopathy caused by sodium valproate].
    Visticot F; Montreuil G
    Rev Med Interne; 1994 May; 15(5):365-6. PubMed ID: 8059168
    [No Abstract]   [Full Text] [Related]  

  • 8. Nondosage-dependent valproic acid-induced hyperammonemia and coma.
    Gaskins JD; Holt RJ; Postelnick M
    Clin Pharm; 1984; 3(3):313-6. PubMed ID: 6428801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Valproate-induced hyperammonemic encephalopathy].
    Diaz-Rangel M; Grande-Martin A; Monsalve-Naharro JA; Domingo-Chiva E; Cuesta-Montero P; Lopez-Perez A
    Rev Neurol; 2017 Dec; 65(12):574-575. PubMed ID: 29235622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced coma: case report and literature review.
    Duarte J; Macias S; Coria F; Fernandez E; Clavería LE
    Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Solomon GE
    Neurology; 2000 Aug; 55(4):606. PubMed ID: 10953214
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sodium valproate, hyperammonemia and hepatic encephalopathy].
    Imler M; Warter JM; Marescaux C
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1042. PubMed ID: 6819177
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of valproate and citrulline on ammonium-induced encephalopathy.
    Stephens JR; Levy RH
    Epilepsia; 1994; 35(1):164-71. PubMed ID: 8112241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid-induced hyperammonaemic coma and unrecognised portosystemic shunt.
    Nzwalo H; Carrapatoso L; Ferreira F; Basilio C
    Epileptic Disord; 2013 Jun; 15(2):207-10. PubMed ID: 23774155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.
    Tokatli A; Coşkun T; Cataltepe S; Ozalp I
    J Inherit Metab Dis; 1991; 14(5):836-7. PubMed ID: 1779634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.